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Introduction: We evaluated the associations between bone marrow lesion (BML) volume change and changes in
periarticular bone mineral density (paBMD) as well as subchondral sclerosis to determine whether BML change is
associated with other local bone changes.
Methods: The convenience sample comprised participants in the Osteoarthritis Initiative (OAI) with weight-bearing
posterior-anterior knee radiographs and magnetic resonance images (MRIs) at the 24- and 48-month visits and
dual-energy x-ray absorptiometry (DXA) at the 30-/36-month and 48-month visits. The right knee was assessed
unless contraindicated for MRI. We used knee DXA scans to measure medial tibia paBMD and medial/lateral paBMD
ratio (M:L paBMD). Knee radiographs were scored for sclerosis (grades 0 to 3) in the medial tibia. Two raters
determined BML volume on sagittal fat-suppressed MRI by using a semiautomated segmentation method. To focus
on knees with only medial tibia BML changes, knees with lateral tibial BMLs were excluded. Medial tibial BML
volume change was classified into three groups: BML regression (lowest quartile of medial tibial BML volume
change), no-to-minimal change (middle two quartiles), and BML progression (highest quartile). We used
proportional odds logistic regression models to evaluate the association between quartiles of changes in medial
paBMD or M:L paBMD ratio, as outcomes, and BML volume change.
Results: The sample (n = 308) included 163 (53%) female subjects, 212 (69%) knees with radiographic osteoarthritis,
and participants with a mean age of 63.8 ± 9.3 years and mean body mass index of 29.8 ± 4.7 kg/m2. We found an
association between greater increases in medial tibia paBMD and BML regression (OR = 1.7 (95% confidence interval
(CI) = 1.1 to 2.8)) and a similar trend for BML progression (OR = 1.6 (95% CI = 1.0 to 2.6]). We also detected
associations between greater increase in M:L paBMD and BML regression (OR = 1.6 (95% CI = 1.0 to 2.7]) and BML
progression (OR = 1.8 (95% CI = 1.1 to 3.0)), although BML regression had borderline statistical significance. The
frequency of sclerosis progression in the medial tibia (n = 14) was greater among knees with BML progression or
regression compared with knees without BML change (P = 0.01 and P = 0.04, respectively).
Conclusion: BML regression and BML progression are characterized by concurrent increases in paBMD and
sclerosis, which are characteristic of increased radiographic osteoarthritis severity. At least during 24 months, BML
regression is not representative of improvement in other periarticular bone measures.* Correspondence: jdriban@tuftsmedicalcenter.org
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Bone marrow lesions (BMLs) are common magnetic reso-
nance (MR) imaging findings among knees with osteo-
arthritis. BMLs are characterized as ill-defined regions
of high-signal intensity within the subchondral bone on
fluid-sensitive MR images that are associated with altered
bone quality (for example, increased bone volume fraction
[1-3], increased periarticular bone mineral density (paBMD)
[4], decreased mineral content [2], fibrosis [3], and edema
[5]). BMLs are clinically meaningful because they are asso-
ciated with knee pain and disease severity (for example,
cartilage damage) as well as predictive of changes in knee
pain and structural progression (for example, cartilage
loss) [6,7]. In recent years, it has been suggested that BML
size may be an important imaging biomarker for knee
osteoarthritis [8] and that reducing BML size (BML re-
gression) may represent an important therapeutic goal for
modifying osteoarthritis progression (for example, pre-
venting or slowing joint-space narrowing) [9,10].
One limitation to adopting BML change as an imaging
outcome for knee osteoarthritis is that the relation bet-
ween BML changes and knee osteoarthritis progression,
as well as other bone changes, remains poorly understood.
Recent evidence suggests that decreases in or resolution
of BMLs (BML regression) is not associated with de-
creased concurrent cartilage loss [6] or joint-space nar-
rowing, and may be associated with greater odds of
joint-space narrowing [6,11]. Based on these findings,
we hypothesize that BML change may not reflect the full
extent of pathologic changes within the periarticular
bone. Therefore, it may be advantageous to determine
the association between BML volume change and con-
current changes in other measures of periarticular bone.
One ideal imaging marker of periarticular bone for tes-
ting this hypothesis is paBMD, which cross-sectionally
is elevated with greater disease severity or intraarticular
pathology (for example, joint-space narrowing [12-15],
osteophytes [14,15], BMLs [4], meniscal pathology [16],
sclerosis [13,15]) and decreases in the medial tibiofe-
moral compartment after unloading (for example, high-
tibial osteotomies) [17]. Subchondral sclerosis is also a
long-recognized finding in knee osteoarthritis and rep-
resents pathology in the periarticular bone. Therefore,
we evaluated the associations between BML volume
change in the medial proximal tibia, measured by using
a validated method [18], and changes in paBMD and
radiographic scoring of subchondral sclerosis. More spe-
cifically, we assessed changes in proximal medial tibia
paBMD [12], which is an absolute change in paBMD,
as well as change in a medial-to-lateral paBMD ratio
(M:L paBMD), which is a relative change in local paBMD
normalized to paBMD from a less-affected region of the
proximal tibia [4,13,16]. Our primary hypothesis was that
BML volume change would have a linear relation withchanges in medial tibia paBMD and M:L paBMD; hence,
an increase in BML volume (BML progression) would be
associated with concurrent increases in medial tibia and
M:L paBMD. Our secondary hypothesis was the BML re-
gression would be associated with a reduced frequency of
progression in sclerosis scores, whereas BML progression
would be characterized by a greater frequency of knees
with progression in sclerosis scores.
Methods
Participant selection
To assess the relation between changes in BML volume
and periarticular bone we selected a convenience sample
from the Osteoarthritis Initiative (OAI, n = 4,796); spe-
cifically the progression subcohort (n = 1,390; Figure 1).
The progression subcohort included participants with
symptomatic radiographic knee osteoarthritis in at least
one knee; defined as a knee with a definite osteophyte
(Osteoarthritis Research Society International (OARSI)
atlas [19] osteophyte grade 1 to 3) and “pain, aching or
stiffness on most days of the month in the last year”.
Within the OAI progression subcohort, the Bone Ancil-
lary Study recruited participants (n = 629) during their
30- or 36-month OAI visits. The inclusion criterion for
this ancillary study was a willingness to undergo additional
knee MR imaging and dual-energy x-ray absorptiometry
(DXA). Exclusion criteria were contraindication for MR
imaging or the presence of bilateral knee replacements.
For these analyses, we focused on participants in the
Bone Ancillary Study with quality magnetic resonance
(MR) imaging at the 24- and 48-month OAI visits
(n = 442) and selected the first 404 knees as a convenience
sample.
This study received ethical approval from each OAI
clinical site (Memorial Hospital of Rhode Island Institu-
tional Review Board, The Ohio State University’s Bio-
medical Sciences Institutional Review Board, University of
Pittsburgh Institutional Review Board, and University of
Maryland Baltimore–Institutional Review Board), the OAI
coordinating center (Committee on Human Research at
University of California, San Francisco), and the Insti-
tutional Review Board at Tufts Medical Center and Tufts
University Health Sciences Campus. All participants pro-
vided informed consent to the OAI and the Bone Ancil-
lary Study.
Magnetic resonance imaging
We evaluated BML volume on sagittal intermediate-
weighted, turbo spin-echo, fat-suppressed MR sequences
(field of view = 160 mm, slice thickness = 3 mm, skip =
0 mm, flip angle = 180 degrees, echo time = 30 ms, reco-
very time = 3,200 ms, 313 × 448 matrix (interpolated to
512 × 512), phase encode superior/inferior, x resolution =
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Figure 1 Selection of analytic set from the Osteoarthritis Initiative.
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Siemens Trio 3-Tesla MR system with a USA Instruments
quadrature transmit-receive knee coil at the 24- and
48-month OAI visits.We focused on the primary OAI knee, which was the
right knee unless there was a contraindication, in which
case, the left knee was the primary knee. Therefore, the
primary knee was not always the knee with symptomatic
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mary knee underwent a complete set of OAI MR se-
quences, whereas the contralateral knee underwent an
abbreviated MR scan to reduce participant burden.
Semiautomated BML segmentation
We used a semiautomated segmentation method to de-
termine BML volume change. We previously demon-
strated the validity of this method with OAI images by
demonstrating that increases in BML volume were asso-
ciated with cartilage loss, and BML volumes differed
across Boston Leeds Osteoarthritis Knee Score [18]. A
detailed description of the segmentation method may be
found in [18].
In brief, two readers measured BML volume with a
semiautomated segmentation method. The only manual
step required a reader to use a graphic user interface
(MATLAB; MathWorks, Inc., Natick, MA, USA) to iden-
tify the crude boundaries of the tibia and femur in each
slice of the MR sequence by marking points along the
articular surface. For the border farthest from the articular
surface, the reader marked the bone just before the epi-
physeal line or at the edge of bone and soft tissue. We
omitted the central slices from the analyses (that is, the
middle nine slices; 2.7 cm), which corresponded to the
subspinous region in the tibia, to focus on BMLs adjacent
to the tibiofemoral chondral surface and to improve
reliability. The central region was automatically detected
after the reader manually marked the most medial and
lateral MR images that included the femoral condyles.
The program automatically refined the initial bone border
to identify more precisely the bone boundaries. Next, the
program automatically applied a thresholding and curve
evolution process twice to segment the areas of high-
signal intensity, which represent a probable BML. We
then used two criteria to eliminate false positive regions
and further to define a BML: (1) the distance between a
BML and the articular surface should be ≤10 mm [20];
and (2) a BML should appear on adjacent images. BML
volumes were calculated for the medial and lateral tibia.
With images from the OAI (n = 10 or 12 knees), we
found good intrareader (intraclass correlation coefficient
(ICC) model 3,1 = 0.79 to 0.99) and interreader reliability
(ICC 2,1 model = 0.59 to 0.93) for BML volume change
[18]. To ensure consistency between readers, a third
investigator reviewed all of the BML segmentations to
verify that the bone segmentation was consistent across
time and knees.
Dual-energy X-ray absorptiometry
To evaluate paBMD, the proximal tibia was scanned by
using DXA (Lunar Prodigy Advance scanner; GE Lunar
Corp., Madison, WI, USA), with a customized knee-
analysis software option. DXA scans were acquired atthe 30- or 36-month and 48-month OAI visits. A stan-
dard protocol [12] was used to ensure that the lower ex-
tremity was positioned and stabilized consistently across
OAI clinical sites. A positioning laser light was used to
center the scanner arm 5 cm below the inferior pole of
the patella.
Periarticular bone mineral density
One analyst performed the paBMD measurements. The
regions of interest (ROIs) were 10 mm vertically, and the
mediolateral (horizontal) direction was half the distance
between the medial and lateral bone edges (creating two
ROIs: medial paBMD and lateral paBMD). The ROIs were
positioned so that the top borders were just superior and
parallel to the joint surfaces of the tibia. For each ROI, the
paBMD was measured in the area bounded by the bone
edges and the boundaries of the ROI positioned within
the bone. A paBMD ratio was derived by dividing the
medial paBMD by the lateral paBMD (M:L paBMD). The
test-retest (with repositioning) intraclass correlation was
0.99 for the tibial paBMD (n = 10). More-specific details
regarding the reliability of these measurements in this data
set have been previously described [12].
Knee radiographs
Bilateral, weight-bearing, fixed-flexion, posterior-anterior
knee radiographs were obtained at the 24- and 48-month
OAI visits. Readers, who were blinded to sequence, scored
the paired images for Kellgren-Lawrence grade (0 to 4) as
well as medial tibial sclerosis grade (0 to 3) and joint space
narrowing by using the OARSI Atlas [19]. The agreement
for these readings (read-reread) was good (weighted
kappa, ≥0.75). Radiographic scores are publicly [21]
(Files: kXR_SQ_BU03_SAS [version 3.4] and kXR_
SQ_BU06_SAS [version 6.2]).
Preliminary analyses
To determine a BML volume threshold for defining a
region with a relevant BML volume, we conducted a
proportional odds logistic regression to determine the
cross-sectional association (48-month visit) between BML
volume and medial tibial paBMD. The outcome was me-
dial tibial paBMD, stratified in quartiles, and the predictor
was medial tibial BML volume, stratified in quartiles. The
model was adjusted for age (<65 years, ≥65 years) and
obesity (body mass index, <30 kg/m2, ≥30 kg/m2). Odds
ratios (ORs) and 95% confidence intervals (CIs) were
computed to compare the upper three quartiles with the
lowest quartile of BML volume (BML volume <0.06 cm3).
The second and third quartiles of BML volume did
not have greater medial tibial paBMD than the first
quartile (second quartile OR = 1.59; 95% CI = 0.89 to
2.84; third quartile OR = 1.50; 95% CI = 0.84 to 2.67).
However, the fourth quartile of BML volume (BML
Table 1 Descriptive baseline characteristics of knees with medial tibia bone marrow lesion (BML) regression,
progression, or no change
Variable BML regression (n = 76) No BML or no BML change
(n = 156)
BML progression (n = 76)
Median (Min, Max) or n (%) Median (Min, Max) or n (%) Median (Min, Max) or n (%)
Age (years) 65 (50, 81) 61 (48, 82) 68 (48, 82)
Body mass index (kg/m2) 29.3 (21.1, 40.9) 29.4 (20.1, 42.0) 29.5 (19.6, 40.7)
Female 40 (52.0%) 85 (54.5%) 38 (50.0%)
Kellgren-Lawrence grade≥ 2 61 (80.3%) 95 (61.3%) 56 (73.7%)
Baseline BML volume (cm3) 0.55 (0.16, 10.98) 0.10 (0.01, 2.94) 0.15 (0.01, 3.51)
Baseline medial tibia paBMD 1.129 (0.681, 1.890) 1.145 (0.761, 1.743) 1.111 (0.800, 1.664)
Baseline M:L paBMD ratio 1.138 (0.799, 1.549) 1.096 (0.794, 1.779) 1.155 (0.914, 1.385)
Number of knees with baseline BML volume ≥0.50 cm3 43 (56%) 7 (4%) 21 (27%)
Notes: paBMD, periarticular bone mineral density; M:L paBMD ratio, medial-to-lateral paBMD ratio.
Driban et al. Arthritis Research & Therapy 2013, 15:R153 Page 5 of 8
http://arthritis-research.com/content/15/5/R153volumes >0.46 cm3) was associated with a higher medial
tibial paBMD than the first quartile (OR = 3.35; 95%
CI = 2.07 to 4.86). Therefore, we adopted an estimate
that a BML volume > 0.50 cm3 represented a region with
a relevant BML volume. Thus, we excluded knees with
lateral tibial BML volumes >0.50 cm3 (at 24- or
48-month OAI visits) because we wanted to ensure that
the lateral tibia was a good reference region for the
M:L paBMD ratio, particularly because we were inte-
rested in changes in the medial tibia.
Statistical analyses
We calculated descriptive statistics to characterize this
study population by using data that are publicly
[21] (Files: allclinical (version 0.2.2, 3.2.1, 6.2.1), enrollees
(version 17)). Before conducting the primary analyses,
we evaluated the point estimates across quartiles of each
continuous independent variable (that is, age, body
mass index, and BML volume change) to verify whether
they had a linear relation with the outcomes. Because
age and body mass index did not have a linear relation
with the outcomes, we converted them to binary vari-
ables based on common cut points. Furthermore, medial
tibia BML volume change did not have a linear relation
with the outcomes and was therefore classified intoTable 2 Descriptive longitudinal characteristics of knees with
progression, or no change
Variable BML regression (n = 76) N
Median (Min, Max) or n (%)
BML volume change (cm3) −0.36 (−8.44, -0.14)
Medial tibia paBMD change (g/cm2) 0.002 (−0.149, 0.164)
M:L paBMD ratio (change) 0.005 (−0.119, 0.291)
Medial tibia sclerosis progression 5 (7.0%)
Notes: paBMD, periarticular bone mineral density; M:L paBMD ratio, medial-to-lateraquartiles. We chose the middle two quartiles of BML
volume change as the reference group. Therefore, medial
tibial BML volume change was classified into three
groups: (1) BML regression (lowest quartile of medial
tibial BML volume change), (2) no-to-minimal change
(middle two quartiles), and (3) BML progression (highest
quartile).
Changes in medial paBMD and M:L paBMD ratio were
calculated as rate of change to control for different obser-
vation periods across the cohort (for example, (follow-up
data – baseline data)/(duration of observation)). We then
calculated quartiles of changes in medial paBMD and
M:L paBMD ratio. We used two proportional-odds logis-
tic regression models to evaluate the association between
quartiles of changes in medial paBMD or M:L paBMD
ratio, as outcomes (y-variables), and change in medial tibia
BML volume (classified into three groups). The models
were adjusted for sex, age (<65 years, ≥65 years), and
obesity (body mass index < 30 kg/m2, ≥30 kg/m2). The
proportional odds assumption was met (medial paBMD:
P = 0.97, M:L paBMD ratio: P = 0.17).
We replicated the primary analyses in two sets of sen-
sitivity analyses. We limited the first sensitivity analysis
to knees with radiographic knee osteoarthritis (Kellgren-
Lawrence score ≥2, n = 212) and the second sensitivitymedial tibia bone marrow lesion (BML) regression,
o BML or No BML change (n = 156) BML progression (n = 76)
Median (Min, Max) or n (%) Median (Min, Max) or n (%)
−0.02 (−0.13, 0.03) 0.21 (0.04, 6.77)
−0.011 (−0.107, 0.149) −0.001 (−0.091, 0.168)
−0.007 (−0.102, 0.091) 0.003 (−0.080, 0.410)
2 (1.3%) 7 (10.0%)
l paBMD ratio.
Table 3 Distribution of medial periarticular bone mineral density (paBMD) changes among knees with medial tibia
bone marrow lesion (BML) regression, progression, or no change (n = 308)
Outcome: Medial paBMD change quartiles (min, max, gm/cm2)
Predictor 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile Proportional
odds ratio(−0.149, -0.033) (−0.032, -0.004) (−0.004, 0.018) (0.018, 0.168)
n = 77 n = 77 n = 77 n = 77 (95% CI)
BML Regression (−8.44, -0.14 cm3) n = 76 16 (21%) 15 (20%) 22 (29%) 23 (30%) 1.72 (1.05 - 2.82)
No BML or no BML change (−0.13, 0.03 cm3) n = 156 45 (29%) 44 (28%) 36 (23%) 31 (20%) Reference
BML Progression (0.04, 6.77 cm3) n = 76 16 (21%) 18 (24%) 19 (25%) 23 (30%) 1.61 (0.98 - 2.65)
Notes: paBMD, periarticular bone mineral density. Proportional odds ratio of greater quartile of medial paBMD is compared with the referent group.
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(n = 276). The proportional-odds assumption was met in
these sensitivity analyses (P > 0.22).
A final sensitivity analysis was conducted among knees
with a baseline medial tibial BML volume ≥0.50 cm3.
We used proportional-odds logistic regression models to
evaluate the association between quartiles of changes in
medial paBMD or M:L paBMD, as the outcomes, and
change in medial tibial BML volume (classified into
three groups). Proportional odds assumption was met
P = 0.86. These final sensitivity analyses were unadjusted
because of the small sample size.
Because only a small number of knees had increased
medial tibia sclerosis scores, we used Fisher Exact Tests
to explore whether the frequency of knees with sclerosis
progression was different between BML volume-change
groups.
Results
The baseline and longitudinal characteristics (n = 308,
excluding those with lateral tibia BMLs) are described in
Tables 1 and 2.
BML volume changes are associated with paBMD changes
We found an association between greater BML reg-
ression and medial tibia paBMD increases (odds ratio
(OR) = 1.72) and a similar trend for BML progression
(OR = 1.61; Table 3). We also detected a similar asso-
ciation of BML regression (OR = 1.64) and BMLTable 4 Distribution of medial-to-lateral periarticular bone m





BML Regression (−8.44, -0.14 cm3) n = 76 14 (18%)
No BML or no BML change (−0.13, 0.03 cm3) n = 156 47 (30%)
BML Progression (0.04, 6.77 cm3) n = 76 16 (21%)
Notes: paBMD, periarticular bone mineral density. Proportional odds ratio of greateprogression (OR = 1.85) with increases in M:L paBMD
ratio, although BML regression had borderline statistical
significance (Table 4).
Sensitivity analyses, conducted among knees with radio-
graphic knee osteoarthritis (n = 212), supported the pri-
mary results. We found an association between greater
medial tibia paBMD change and BML regression (OR =
2.07; 95% CI = 1.15 to 3.73) and BML progression (OR =
1.83; 95% CI, 1.00 to 3.36). Similarly, greater M:L paBMD
ratio change showed a similar trend with BML regression
(OR = 1.74; 95% CI, 0.97 to 3.12) and BML progression
(OR = 1.90; 95% CI = 1.03 to 3.49).
Sensitivity analyses, conducted among knees without
lateral joint-space narrowing (n = 276), also supported
the primary results. We found an association between
greater medial tibia paBMD change and BML regression
(OR = 1.78; 95% CI, 1.05 to 3.03) and BML progression
(OR = 1.68; 95% CI, 1.00 to 2.82]). Similarly, greater M:L
paBMD ratio change had a similar trend with BML re-
gression (OR = 1.55; 95% CI, 0.91 to 2.63) and BML pro-
gression (OR = 1.79; 95% CI, 1.06 to 3.01]).
Sensitivity analyses, conducted among knees with a
baseline medial tibial BML volume ≥0.50 cm3 (n = 71),
supported the primary results for medial tibia paBMD
change but not M:L paBMD change (P = 0.87). We found
an association between greater medial tibia paBMD
change and BML regression (OR = 5.97; 95% CI, 1.28
to 27.86) and BML progression (OR = 7.44; 95% CI, 1.43
to 38.68).ineral density (M:L paBMD) changes among knees with
n, or no change (n = 308)
lateral paBMD ratio change quartiles (min, max)
2nd Quartile 3rd Quartile 4th Quartile Proportional
odds ratio(−0.021, 0.000) (0.000, 0.022) (0.022, 0.410)
n = 77 n = 77 n = 77 (95% CI)
18 (24%) 25 (33%) 19 (25%) 1.64 (1.00 – 2.69)
45 (29%) 30 (19%) 34 (22%) Reference
14 (18%) 22 (29%) 24 (32%) 1.85 (1.12 – 3.04)
r quartile of medial paBMD is compared with the referent group.
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progression
Exploratory analyses indicated that the frequency of
sclerosis progression in the medial tibia was greater
among knees with BML progression or regression com-
pared with knees with no BML change (Table 2; P = 0.01
and P = 0.04, respectively).
Discussion
Bone marrow lesions are associated with regions of in-
creased paBMD [4], which is related to greater osteo-
arthritis severity (for example, joint-space narrowing,
subchondral sclerosis) [13]. We found that compared
with knees with no BML change, BML progression and
BML regression were associated with increased paBMD
and sclerosis in the medial tibia, reflective of radio-
graphic osteoarthritis progression. These findings may
provide an explanation for why a decrease in BML vo-
lume is not associated with decreased odds of structural
progression (for example, cartilage loss, joint-space nar-
rowing) [6,11]. Overall, these analyses suggest that BML
regression may not represent a concurrent improvement
in other periarticular bone measures (that is, subchon-
dral sclerosis and paBMD).
These findings improve our understanding of BMLs and
BML changes. Bone marrow lesions are characterized as
areas of increased bone-volume fraction [1-3], increased
paBMD [4], decreased mineral content [2], fibrosis [3],
edema [5], and necrosis, which can change size in short
periods (for example, 6 to 12 weeks) [8]. The rapid
changes in BML size, which have been previously reported
[8], may correspond to changes in bone marrow (for
example, edema, fibrosis) that could be associated with
changes in knee pain [7,22], but not changes that in-
fluence bone morphometry (for example, trabecular
morphometry, bone mineral density, bone mineral con-
tent), which may take longer to remodel. Therefore, the
MR-imaging signal associated with changes in BML may
be an imaging biomarker that is associated with imme-
diate changes in pain stimuli but not overall bone. It is im-
portant to note that conflicting data exist on the relation
between BML size and knee pain; however, recent syste-
matic reviews support this association [7,22]. Reducing
BML size may be an important therapeutic target for de-
creasing knee pain, but thus far, its importance in modify-
ing structural progression remains doubtful over the short
term (<2 years) and requires additional research for longer
observation periods.
This study offers new insights into BMLs, but it is im-
portant to note that we used an apparent measure of
bone density that included cortical bone. It may be ad-
vantageous for future studies to explore this question
with measures of trabecular morphometry along with
MR spectroscopic imaging, which may detect changes inthe bone marrow. Future studies will also be needed to
understand whether BML regression eventually leads to
improved bone measures and decreased risk of osteo-
arthritis progression over the long term (for example,
cartilage loss, joint-space narrowing). These studies may
also require more-frequent imaging to determine when
the BML changes are occurring because it is unclear in
these analyses if the BML change occurred gradually
over a 2–year period or in short periods during the
observation period. More-frequent assessments may also
address the implications of bone exposed to repeated
appearances of BMLs. The utility of BML change as
an outcome in clinical trials and as a potential target
for disease-modifying interventions will remain doubtful
until these lingering issues are addressed.
Another limitation to our study was that we had a
small sample size of individuals with baseline BML vo-
lume ≥0.50 cm3 (n = 71) and changes in sclerosis scores
(n = 14). Despite this small sample size, we were able to
detect longitudinal associations in unadjusted analyses
that supported the primary results. Future studies could
try to pursue a larger sample size to address these ana-
lyses or opt for direct assessments of bone.
Conclusions
We propose that BML regression and BML progression
are characterized by concurrent increases in paBMD and
sclerosis, which are characteristic of increased radio-
graphic osteoarthritis severity. At least during 24 months,
it appears that BML regression is not representative of
improvement in other bone measures. Therefore, BML
change may represent a transient phase of the natural
history of periarticular bone changes in OA.
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